case:
  id: "KJ_CRISPR2"
  title: "In vivo CRISPR 2.0 base editing for CPS1 gene mutation"
  source: "https://www.nejm.org/doi/full/10.1056/NEJMoa2504747"
genome:
  patient_id: "KJ"
  diagnosis: "CPS1 deficiency"
  mutation_paternal: "[MUT:PAT:G>A@Q335X]"
  mutation_maternal: "[MUT:MAT:G>A@E714X]"
  tissue: "hepatocyte"
editor:
  type: "ABE"
  model_used: "K-abe"
  delivery: "mRNA + LNP"
  target_site: "[MUT:PAT:G>A@Q335X]"
  dose_schedule:
    - day: 0
      dose: low
      response: minimal
    - day: 21
      dose: mid
      response: "↓ ammonia"
    - day: 42
      dose: high
      response: "↑ metabolic stability"
symbolic_design:
  - "~d:[TATA]CPS1[TF(HNF4A)][MUT:PAT:G>A@Q335X]"
  - "EDIT:Base(A→G@Q335X){tool=ABE, cells=hepatocyte}"
  - "DELIV(mRNA+LNP@IV)"
  - "DOSE(1-3)"
notes:
  - "First in vivo base editing in a human infant"
  - "No liver biopsy due to risk; phenotype-based evaluation"
  - "Non-viral delivery avoided immune reaction"
